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Phi Luong1, Jay R. Thiagarajah1,2,3, Adrienne W. Paton8, James C. Paton8, Markus A. Seeliger9, Sven Eyckerman4, Sophie Janssens5, and
Wayne I. Lencer1,2,3
IRE1β is an ER stress sensor uniquely expressed in epithelial cells lining mucosal surfaces. Here, we show that intestinal
epithelial cells expressing IRE1β have an attenuated unfolded protein response to ER stress. When modeled in HEK293 cells and
with purified protein, IRE1β diminishes expression and inhibits signaling by the closely related stress sensor IRE1α. IRE1β can
assemble with and inhibit IRE1α to suppress stress-induced XBP1 splicing, a key mediator of the unfolded protein response. In
comparison to IRE1α, IRE1β has relatively weak XBP1 splicing activity, largely explained by a nonconserved amino acid in the
kinase domain active site that impairs its phosphorylation and restricts oligomerization. This enables IRE1β to act as a
dominant-negative suppressor of IRE1α and affect how barrier epithelial cells manage the response to stress at the
host–environment interface.
Introduction
All mammalian cell types have three sensors in the ER, IRE1α,
ATF6, and PERK, which detect imbalances in protein folding and
trigger an integrated set of signaling pathways to restore normal
proteostasis. This is called the unfolded protein response (UPR).
If protein folding in the ER remains unresolved, prolonged UPR
signaling induces cell death (Chang et al., 2018; Hetz and Papa,
2018; Lu et al., 2014; Walter and Ron, 2011). Epithelial cells lining
the intestine and other mucosal surfaces that interface with the
environment are unique in that they express an additional ER
stress sensor called IRE1β (ERN2 gene; Bertolotti et al., 2001;
Iwawaki et al., 2001; Martino et al., 2013; Tsuru et al., 2013;
Wang et al., 1998). IRE1β is a close paralogue of the ubiquitously
expressed IRE1α (Tirasophon et al., 1998). Both are dual kinase/
endonucleases that splice XBP1 mRNA to produce the tran-
scription factor XBP1, which functions to induce the UPR (Calfon
et al., 2002; Lee et al., 2002; Yoshida et al., 2001). Both IRE1α and
IRE1β can also degrade othermRNA sequences targeted to the ER
for translation, termed regulated IRE1-dependent decay of
mRNA (or RIDD; Hollien et al., 2009; Hollien and Weissman,
2006; Imagawa et al., 2008; Iwawaki et al., 2001; Tsuru et al.,
2013), including for IRE1α the ability to autoregulate its own
expression by degrading its own mRNA (Tirasophon et al.,
2000). Despite the high degree of sequence homology between
the two molecules, IRE1β and IRE1α appear to have distinct en-
zymatic activities, and how IRE1β functions in the ER stress
response remains inconclusively defined. In cell culture, some
studies show that IRE1β can sense ER stress and activate the UPR
by splicing XBP1 transcripts (Tirasophon et al., 2000; Wang
et al., 1998), but other reports suggest it is less effective than
IRE1α at splicing XBP1 and signals through other mechanisms to
mitigate ER stress (Imagawa et al., 2008; Iwawaki et al., 2001).
In vivo, under normal physiological conditions, the intestine
and colon of mice lacking IRE1β (IRE1β−/−) show evidence of an
elevated UPR compared with WT controls, including increased
levels of spliced XBP1 transcript indicative of IRE1α activation
(Bertolotti et al., 2001; Tschurtschenthaler et al., 2017; Tsuru
et al., 2013). The phenotype suggests that IRE1β may function
to suppress IRE1α activity and perhaps other elements of the
UPR. Such a role for IRE1β in diminishing ER stress in the in-
testine was most recently implicated in mice conditionally
lacking both the IRE1α substrate XBP1 and the autophagy factor
ATG16L1 (Tschurtschenthaler et al., 2017). At the molecular
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level, activation of IRE1α by ER stress appears to require homo-
oligomerization and autophosphorylation (Bertolotti et al., 2000;
Li et al., 2010). Given the close homology between the two pro-
teins, we became interested in testing the hypothesis that IRE1β
may modulate the UPR by interacting and assembling directly
with IRE1α. We examined IRE1β function in intestinal epithelial
cells, HEK293 cells, and in vitro using purified proteins. Our cell
and biochemical data show that IRE1β dampens the UPR to ER
stress. IRE1β restricts ER stress–induced IRE1α endonuclease
activity, as assessed by XBP1 splicing, and it reverses the in-
creases in IRE1α and XBP1 expression expected for the UPR. We
define structural features of the IRE1β kinase domain that con-
tribute to these effects and enable IRE1β to act as a direct and
dominant-negative suppressor of IRE1α signaling. This activity
appears to have been evolutionarily conserved in epithelial cells
lining the mucosa of vertebrates, perhaps, as proposed before
(Bertolotti et al., 2001), to dampen amplified ER stress responses
inherent to the host–environment interface.
Results
Cells expressing IRE1β exhibit attenuated UPR signaling
Previous studies suggest that IRE1β restricts IRE1α and UPR sig-
naling in vivo under normal homeostatic conditions (Bertolotti
et al., 2001; Tschurtschenthaler et al., 2017; Tsuru et al., 2013).
To test this idea, we compared the UPR in polarized human in-
testinal epithelial cell lines expressing different levels of IRE1β.
The human intestinal T84 cell line expresses IRE1β transcript, but
the human intestinal Caco2 cell line does not (>500-fold differ-
ence; Fig. 1 A, inset). When treated with thapsigargin (Tg) to in-
duce ER stress, Caco2 cells responded with robust activation of all
three branches of the UPR, as seen by increases in mRNA for BiP,
ATF4, CHOP/DDIT3, and spliced XBP1 (Fig. 1 A, purple bars). They
also responded with increased IRE1α mRNA expression as ex-
pected for the UPR. In comparison, T84 cells had significantly
reduced induction of mRNA for these genes (Fig. 1 A, light blue
bars). Similar results were obtained using primary intestinal co-
lonoids prepared fromWT (IRE1β+/+) or IRE1β−/−mice (Fig. 1 B). In
this case, ER stress was induced using subtilase cytotoxin (SubAB;
Paton et al., 2006; Paton et al., 2004). Thus, in intestinal cells,
IRE1β expression is correlated with reduced IRE1α and UPR sig-
naling in response to ER stress.
To test if IRE1β was sufficient to attenuate the UPR, we
generated a HEK293 cell model with doxycycline (Dox)–
inducible expression of FLAG-tagged IRE1β (HEK293doxIRE1β).
Dox treatments induced IRE1β expression in a dose-dependent
manner (Fig. 1 C). At the transcript level, this corresponded to
∼10- and 100-fold higher levels of IRE1β relative to endogenous
IRE1α after treatments with 10 or 100 ng/ml Dox, respectively
(Fig. 1 D). Similar levels of expression for IRE1β relative to IRE1α
were observed in normal mouse small intestine (Haber et al.,
2017). In goblet cells, for example, the IRE1β/IRE1α mRNA
transcript ratios as measured in single cells ranged from 2:1 to
384:1, with a mean value of 51:1 (Fig. S1 A). In the absence of
IRE1β (no Dox), Tg treatment of HEK293doxIRE1β cells caused the
expected induction of a conventional UPR transcriptional pro-
gram (Fig. 1 E and Data S1), including up-regulation of HSPA5,
ATF4, DDIT3, XBP1, and IRE1α. When HEK293doxIRE1β cells were
induced to express IRE1β by treatment with Dox, there was a
dose-dependent reduction in stress-induced UPR gene expression
and correspondingly less enrichment of differentially expressed
genes in the UPR signature (reduced on average by 1.2-fold and
1.8-fold). Dox treatment on its own did not affect UPR signaling in
mock-transduced cells (HEK293mock, Fig. S1, B and C). Thus, IRE1β
can attenuate stress-induced UPR signaling.
IRE1β suppresses IRE1α-XBP1 signaling
To study how IRE1β affects IRE1α signaling, we first measured
splicing of XBP1 mRNA, a reaction specific to the IRE1-branch
of the UPR. In HEK293doxIRE1β cells lacking IRE1β, Tg treat-
ment resulted in the expected increase in XBP1 splicing as
measured by the ratio of spliced to unspliced XBP1 transcript
(Fig. 2 A, first two lanes and purple bars) and by quantitative
PCR (qPCR; Fig. 2 B, purple bars). The induction of IRE1β
expression dose-dependently increased the level of XBP1
splicing in cells at rest (no Tg treatment) compared with cells
without Dox (Fig. 2, A and B, no Tg), consistent with XBP1
splicing by IRE1β itself or secondarily by activation of IRE1α.
When treated with Tg to induce ER stress, however, the ex-
pression of IRE1β in HEK293doxIRE1β cells dose-dependently
attenuated the further splicing of XBP1 (Fig. 2, A and B, +
Tg), and cells expressing high levels of IRE1β have signifi-
cantly less spliced XBP1 in response to ER stress compared
with control cells (Fig. 2, A and B, 100 ng/ml Dox versus no
Dox). This was associated with marked decreases in stress-
induced expression of XBP1-dependent genes (Fig. 2 C). Con-
sistent with this expression profile, IRE1β reduced XBP1
transcriptional activity, as seen in HEK293T cells expressing a
UPRE-luciferase reporter (Wang et al., 2000; Fig. S2 A; the
transient expression of IRE1β in HEK293T cells also reduced
spliced XBP1 mRNA and protein as seen in HEK293doxIRE1β
cells, Fig. S2, B and C). Coexpression of XBP1 protein in this
model rescued UPRE reporter activity, indicating that IRE1β
acts upstream of XBP1s. Thus, IRE1β impairs the stress re-
sponse normally mediated by IRE1α-XBP1 signaling.
The suppression of IRE1α signaling, however, was not ap-
parent for RIDD signaling as measured by mRNA levels of
known RIDD targets, including BLOC1S1 (Hollien et al., 2009). In
control cells, in the absence of IRE1β, the induction of ER stress
by Tg treatment resulted in decreased expression for all RIDD
target genes as expected (Fig. 2 D, columns 1 versus 2; and Data
S1). Expression of IRE1β in cells not treated with Tg (no ER
stress) resulted in decreased expression of all RIDD targets (Data
S1, compare columns 1, 3, and 5). And, following Tg treatment,
mRNA levels were further decreased (lanes 3 vs. 4, and lanes 5
vs. 6). On average, the stress-induced fold-change for all RIDD
targets tended to be greater in IRE1β expressing cells (Fig. 2 E,
left panel bar graph), where six of the eight RIDD genes studied
showed a more pronounced stress-induced response (Fig. 2 E,
left panel individual gene plots), compared with control cells.
Thus, unlike the attenuated stress-induced XBP1 splicing when
IRE1β is expressed (Fig. 2 E, right panel), the stress-induced
RIDD activity appears to remain largely intact and perhaps
even enhanced.
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Suppression of IRE1α expression does not explain how IRE1β
affects the UPR
The UPR amplifies IRE1α expression in HEK293doxIRE1β cells
(Fig. 3, A–C, no Dox purple bars; and Fig. S3 for HEK293T cells)
as has been reported previously (Tsuru et al., 2016). We found
this effect was mediated, at least in part, by XBP1s, where four
putative XBP1 binding sites in the IRE1α promoter were re-
sponsive to both XBP1s transient expression or the induction of
ER stress (Fig. 3 D and Data S2). However, when IRE1β expres-
sion was induced in HEK293doxIRE1β cells (or by transient
transfection in HEK293T cells), we observed significantly re-
duced IRE1α mRNA and protein levels at rest (in the absence of
Tg) and no detectable up-regulation of IRE1α after the induction
of ER stress (Fig. 3, A–C, Dox treated; and Fig. S3). Both results
are consistent with IRE1β suppression of IRE1a XBP1 splicing.
Thus, one explanation for how IRE1β may reduce IRE1α–XBP1
signaling could be by transcriptional suppression of IRE1α. To
test this possibility, we used siRNA to knockdown IRE1α in
HEK293doxIRE1b cells. Both IRE1αmRNA and proteins levels were
reduced more than fourfold compared with control cells trans-
fected with nontargeting siRNA (Fig. 3 E). Nonetheless, these
cells still responded to ER stress by splicing XBP1 at levels
comparable to control cells (Fig. 3 F). We conclude that the lower
levels of IRE1α expression seen in ourmodel cannot fully explain
the impaired ER stress response caused by IRE1β, suggesting
other mechanisms of action.
IRE1β enzymatic activities are not required
Like IRE1α, IRE1β has cytosolic kinase and endonuclease domains.
To test if these enzymatic activities are required to suppress XBP1
splicing, we prepared IRE1β expression constructs with in-
activating point mutation in the kinase domain (IRE1βK574A) or
with deletion of the endonuclease domain (IRE1β(Δ783–925); Fig. 4
A). Full-length IRE1β or mutant IRE1βwas then coexpressed along
with a luciferase reporter for XBP1 splicing (Iwawaki and Akai,
2006) in HEK293T cells that contain endogenous IRE1α. All IRE1β
constructs were expressed at similar protein levels (Fig. 4 A,
bottom panel). ER stress was induced using Tg or SubAB or its
enzymatically inactivemutant (SubAA272B) as control (Paton et al.,
2006; Paton et al., 2004). In cells at rest (baseline, Fig. 4 B), ex-
pression of WT IRE1β caused an increase in XBP1 splicing (lucif-
erase reporter activity) as we saw before in HEK293doxIRE1β cells.
Figure 1. Cells expressing IRE1β exhibit at-
tenuated UPR signaling. (A) Tg-induced mRNA
expression of UPR genes assayed by qPCR for
polarized Caco2 and T84 monolayers (log2 [Tg-
treated/DMSO control], n = 3). (B) Subtilase
cytotoxin-induced mRNA expression of UPR
genes assayed by qPCR for IRE1β+/+ and IRE1β−/−
mouse primary colonoids (log2 [SubAB-treated/
SubAA272B-treated], n = 3). (C) IRE1β expression
assayed by immunoblot (representative of three
experiments). (D) IRE1β/IRE1α transcript ratio as-
sayed by qPCR (n= 8). (E) Stress-induced differential
expression of UPR markers (Tg compared with
DMSO) was assayed by RNA-seq for HEK293doxIRE1β
cells treated with Dox and Tg as indicated (n = 3).
The anti-FLAG and anti-βactin immunoblots are
duplicated in Fig. S1 B and Fig. 3 B, as the same
experiment was used to assess expression in mock-
transduced cells (Fig. S1 B) and IRE1α expression
(Fig. 3 B). Bars and error bars representmean values±
SEM; significance is indicated by asterisks (*, P < 0.05;
**, P < 0.01; ***, P < 0.001; ****, P < 0.0001).
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But expression of the IRE1βmutants lacking kinase activity or the
endonuclease domain did not. Thus, in cells expressing IRE1β, the
increased levels of XBP1s at baseline are explained by the endo-
nuclease activity of IRE1β and not by secondary activation of ER
stress. In the presence of ER stress, however, transfection of WT
IRE1β or either mutant protein significantly reduced XBP1 splicing
(measured as reporter activity; Fig. 4 C), indicating that enzymatic
activities are not required.
IRE1β can assemble with IRE1α
We next wanted to test if IRE1β interacts directly with IRE1α.
We first used HEK293doxIRE1β cells for coimmunoprecipitation
studies. In Dox-treated cells expressing IRE1β (FLAG tagged),
immunoprecipitation of IRE1β from total cell lysates using anti-
FLAG antibody coimmunoprecipitated endogenous IRE1α as as-
sessed by immunoblot (Fig. 5 A). Notably, IRE1α and IRE1β were
coimmunoprecipitated in the absence of Tg, suggesting that
IRE1β may constitutively interact with IRE1α. Similar results
were obtained using HEK293 cells transiently transfected with
FLAG-tagged IRE1β (Fig. S4). Thus, IRE1β appears to physically
interact with IRE1α. As an additional test of interaction between
IRE1α and IRE1β, we fractionated HEK293doxIRE1β cell lysates by
gel filtration chromatography and assayed for IRE1α and IRE1β
elution. In cells lacking IRE1β, the induction of ER stress shifted
the elution of IRE1α from ∼15 ml in untreated cells to ∼14 ml in
Tg-treated cells (Fig. 5 B, top two blots and graph with purple
Figure 2. IRE1β suppresses IRE1α–XBP1 signaling. (A and B) XBP1 splicing was assayed by (A) PCR and gel electrophoresis to detect spliced and
unspliced XBP1 or (B) qPCR to detect spliced XBP1 transcript in HEK293doxIRE1β cells treated with Dox and Tg as indicated (n = 3). (C) Same as in A, with
differential expression of XBP1 genes assayed by RNA-seq. Data are shown for stress-induced expression (Tg compared with DMSO, left panel) for all
genes in signature that are differentially expressed for control cells (No Dox, n = 3). (D) Same as in C for indicated RIDD targets relative to control cells
(No Dox) without stress treatment (No Tg). (E) Left: Stress-induced changes in expression of RIDD targets for cells treated with indicated concentrations
of Dox. Bars represent the average fold change for all targets. The symbols represent the mean fold change for an individual target gene. Right: Stress-
induced fold change in spliced XBP1 transcript replotted from qPCR data in B. Bars and error bars represent mean values ± SEM; significance is indicated
by asterisks (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001).
Grey et al. Journal of Cell Biology 4 of 17
IRE1β negatively regulates IRE1α signaling https://doi.org/10.1083/jcb.201904048
D
ow
nloaded from
 https://rupress.org/jcb/article-pdf/219/2/e201904048/853375/jcb_201904048.pdf by U
niversiteit G
ent user on 13 April 2020
lines/symbols). This is consistent with the formation of higher-
order oligomers associated with IRE1α activation (Bertolotti
et al., 2000; Li et al., 2010). Expression of IRE1β, on the
other hand, shifted IRE1α elution to higher apparent molec-
ular weight even in the absence of ER stress (no Tg); this was
more pronounced following Tg treatment (Fig. 5 B, bottom
two blots and graph with light blue lines/symbols). IRE1β
coeluted with IRE1α under these conditions (Fig. 5 B, anti-
FLAG immunoblots). These results suggest that IRE1β and
IRE1α may form mixed oligomeric species.
IRE1β inhibits IRE1α endonuclease activity in vitro
To test if this physical interaction inhibits IRE1α function, we
used recombinant proteins in vitro. Full-length Myc-tagged
Figure 3. Suppression of IRE1α expression does not explain how IRE1β affects the UPR. (A–C) IRE1α expression was assayed by (A) qPCR for mRNA or (B)
immunoblot for protein in HEK293doxIRE1β cells treated with Tg for indicated time points (immunoblots are representative of two or three independent ex-
periments). The anti-βactin blot for the 3-h Tg treatment (fourth row down) is duplicated from Fig. 1 C, as the same experiment and membrane was used to
probe for anti-FLAG (Fig. 1 C), anti-IRE1α, and anti-βactin. The actin normalized band intensities are plotted in C. For A and C, data are plotted as log2 fold
change relative to 0 ng/ml Dox without Tg. Each experiment for a given time point included a control sample without Tg. (D) Top: Schematic of human IRE1α
gene (ERN1) promoter region and luciferase reporter constructs. Putative XBP1 binding sites are indicated as boxes. (Bottom panel) IRE1α-Luc reporter activity
in HEK293T cells (left) cotransfected with either control vector or XBP1 expression vector or (right) treated with SubAA272B or SubAB (100 ng/ml) for 8 h (n = 3).
(E) IRE1α protein and mRNA levels in HEK293doxIRE1β cells transfected with IRE1α siRNA or control siRNA and treated with Tg (n = 2). (F) Same as in E for spliced
XBP1 mRNA. Bars and error bars represent mean values ± SEM; significance is indicated by asterisks (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001).
Grey et al. Journal of Cell Biology 5 of 17
IRE1β negatively regulates IRE1α signaling https://doi.org/10.1083/jcb.201904048
D
ow
nloaded from
 https://rupress.org/jcb/article-pdf/219/2/e201904048/853375/jcb_201904048.pdf by U
niversiteit G
ent user on 13 April 2020
IRE1α and IRE1βwere expressed and purified from Expi293 cells
(Fig. 6 A) and confirmed by immunoblot andmass spectrometry.
Endonuclease activity of the purified proteins was measured
in vitro using the XBP1 reporter substrate (Wiseman et al.,
2010). Incubation of the reporter substrate with purified full-
length IRE1α resulted in a robust increase in fluorescence on the
time scale of minutes, consistent with enzymatic cleavage of the
reporter substrate (Fig. 6 B, top). Reactions with purified full-
length IRE1β, on the other hand, showed no detectable increase
in fluorescence on the same time scale (Fig. 6 B, bottom). The
purified IRE1β protein was nonetheless active, though with
much weaker endonuclease activity and slower kinetics (Fig. 6
B, bottom panel inset). Similarly, IRE1β exhibited weaker XBP1
splicing activity than IRE1αwhen expressed in HEK293/IRE1αKO
cells (Fig. S5, A and B) as described previously (Imagawa et al.,
2008). When the purified proteins were assayed in vitro under
steady-state conditions, IRE1α exhibited classicalMichaelis–Menten
kinetics for cleavage of the XBP1 reporter with reproducibly similar
Michaelis constant (KM) values from different batches of protein
(preparation 1: KM = 1.9 ± 0.3 µM; preparation 2: KM = 2.0 ± 0.3
µM). When assayed in the presence of IRE1β (at fivefold molar
excess), the maximal reaction velocity was reduced by 15–25%
(Fig. 6 C, light blue curves). The change in maximum velocity
(Vmax) was reproduced in multiple experiments and with two
independently prepared batches of purified protein. When ana-
lyzed using a noncompetitive inhibitor model, the reduction in
Vmax corresponded to an inhibitory constant of KI ≈ 300 nM. It is
unlikely at these concentrations that IRE1β affects Vmax by
binding and sequestering substrate (only a few percent of sub-
strate would be affected), and even if so, this would have a
negligible effect on the analysis using the noncompetitive in-
hibitor model. Thus, IRE1β can interact directly with IRE1α to
inhibit its function.
We also tested this by adding purified IRE1β to lysates of
cells expressing IRE1α-mCherry. The placement of a C-terminal
mCherry tag did not impair XBP1 splicing compared with untagged
Figure 4. IRE1β enzymatic activity is not required to suppress stress-induced XBP1 splicing. (A) Schematic of IRE1β constructs. All constructs have
C-terminal Myc tag. Expression of constructs in HEK293T cells was assayed by immunoblot with anti-Myc antibody. (B and C) XBP1 splicing activity was
measured using a luciferase reporter in HEK293T cells cotransfected with indicated IRE1β expression plasmids and stimulated with either Tg or SubAB.
Luciferase activity is plotted (B) as the fold change relative to mock-transfected, control-treated cells at baseline or (C) as the stress-induced fold change
relative to control for a given IRE1β construct (n = 3). Bars and error bars represent mean values ± SEM; significance is indicated by asterisks (*, P < 0.05; **, P <
0.01; ***, P < 0.001; ****, P < 0.0001).
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IRE1α when overexpressed in HEK293/IRE1αKO cells; both
were similarly active even in the absence of Tg when assayed
using the XBP1 splicing luciferase reporter (Fig. S5 C). In the
absence of IRE1β, IRE1α-mCherry eluted from gel filtration as
a broad peak between 13 and 14 ml elution volume (Fig. 6 D,
top panel). When the fraction at 13 ml (shaded symbol in
Fig. 6 D, top panel) was reinjected on gel filtration, IRE1α-
mCherry eluted as a lower-molecular-weight species at 14 ml
and higher-molecular-weight species at 13 ml, suggesting that
these species are in dynamic equilibrium (Fig. 6 D, middle
panel, purple trace). Endonuclease activity predominantly
coeluted with the higher-molecular-weight species (Fig. 6 D,
bottom panel, purple trace), suggesting this is the active form
of IRE1α-mCherry. When the same 13-ml fraction was incu-
bated with purified IRE1β and reinjected on gel filtration,
IRE1α-mCherry had a similar elution profile (Fig. 6 D, middle
panel, light blue trace) but with less endonuclease activity
coeluting with the higher-molecular-weight species (Fig. 6 D,
bottom panel, compare light blue and purple traces). Similar
results were obtained in HEK293 cells coexpressing IRE1α-
mCherry and IRE1β. IRE1β expression was associated with
less specific endonuclease activity coeluting in the higher-
molecular-weight fractions (Fig. 6 E). Thus, IRE1β appears to
inhibit IRE1α endonuclease activity by physical interaction.
IRE1β has impaired autophosphorylation and does not form
higher-order oligomers
We next wanted to understand what mechanisms dictate the
distinct enzymatic outputs. To a large extent, IRE1β behaved in
these studies similarly to a kinase-dead version of IRE1α, which
also has weak endonuclease function and has been shown to act
as a dominant-negative inhibitor of endogenous IRE1α XBP1
splicing (Tirasophon et al., 1998). In our hands, overexpression
of the kinase-dead IRE1α(K599A) mutant in HEK293 cells
Figure 5. IRE1β interacts with IRE1α. (A) IRE1α
and IRE1β proteins were assayed by immunoblot
with anti-IRE1α or anti-FLAG antibodies, respec-
tively, for lysates or samples immunoprecipitated
with anti-FLAG from HEK293doxIRE1β cells treated
with Dox and Tg as indicated. Blots are represen-
tative of three independent experiments. (B) Oligo-
merization of endogenous IRE1α was assayed by gel
filtration fractionation of lysates fromHEK293doxIRE1β
cells and immunoblot with anti-IRE1α antibody.
Fraction band intensities are plotted relative to the
band intensity for the input sample, which was in-
cluded on each gel, and normalized to fractions with
the highest relative intensity (assigned a value of 1)
and lowest relative intensity (assigned a value of 0).
Symbols represent mean ± range for two indepen-
dent experiments.
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blocked stress-induced XBP1 splicing reporter activity (Fig. 7
A). When the IRE1α(K599A) kinase-dead mutant was coex-
pressed with fluorescently tagged WT IRE1α-mCherry in
HEK293 cells, the gel filtration elution profile of IRE1α-mCherry
was shifted slightly to lower-molecular-weight fractions
(perhaps reflecting assembly of mixed oligomers) with a
concomitant loss of in vitro endonuclease activity in each
fraction (Fig. 7 B). This result phenocopied our results with
IRE1β (Fig. 6 E) and underscores the biological plausibility that
IRE1β, like the kinase-dead IRE1α(K599A) mutant, may act in a
dominant-negative manner to suppress stress-induced IRE1α
signal transduction.
The similar molecular phenotypes for the kinase-dead
IRE1α(K599A) mutant and WT IRE1β suggested that IRE1β
function might be explained by deficient kinase activity and
impaired (or altered) autophosphorylation in native IRE1β. To
Figure 6. IRE1β inhibits IRE1α endonuclease activity in vitro. (A) Samples of affinity-purified full-length IRE1α and IRE1βwere separated on SDS-PAGE and
stained with Coomassie blue or assayed by immunoblot with anti-IRE1α, anti-IRE1β, or anti-Myc antibodies. (B) In vitro endonuclease activity was assayed by
monitoring cleavage of fluorescent reporter substrate (10 nM) over time for indicated concentrations of (top, purple) IRE1α or (bottom) IRE1β. Bottom, inset:
Endonuclease activity monitored over 24 h for 250 nM IRE1β (light green) or buffer control (black circles). (C) Steady-state kinetics were assayed by measuring
progress curves for 10 nM IRE1α or 10 nM IRE1α + 50 nM IRE1β as a function of reporter substrate concentration. Kinetic data are plotted as initial reaction
velocity versus substrate concentration. Data were measured for two independent preparations of purified protein, with symbols representing mean ± SEM for
three independent measures for preparation 1 (Prep#1) or values from a single measurement for preparation 2 (Prep#2). Solid lines represent best fit of a non-
competitive inhibitor model to the kinetic data. (D) Top: Gel filtration chromatogram for lysate of HEK293 cells expressing IRE1α-mCherry. A high-molecular-weight
(HMW) fraction (indicated by filled symbol in top panel) was incubated with either buffer (purple traces) or purified IRE1β (100 nM, light blue traces), reinjected on
gel filtration, and assayed for mCherry fluorescence (middle panel) and endonuclease activity (bottom panel). (E) Gel filtration chromatograms for lysates of HEK293
cells expressing IRE1α-mCherry alone or coexpressing IRE1α-mCherry and IRE1β-MycHis. IRE1α-mCherry elution was assayed by mCherry fluorescence (solid lines),
and endonuclease activity (symbols, dashed lines) was measured for individual fractions with model XBP1 reporter substrate. Endonuclease activity is plotted as a.u.
min−1 mCherry−1.
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test this idea, we first applied our purified proteins to an
autophosphorylation assay in vitro. IRE1β had comparatively
weaker kinase activity than IRE1α (Fig. 7 C), and, when as-
sessed by mass spectrometry, IRE1α and IRE1β isolated from
HEK293 cells had different patterns of phosphorylation. In
two independent preparations, IRE1α had phosphorylation on
S724, S726, and S729 in the activation loop of the kinase do-
main, phosphorylation sites that are associated with increased
IRE1α endonuclease activity (Prischi et al., 2014). Phospho-
rylation was not detected for the equivalent activation loop
Ser residues in IRE1β (Fig. 7 D and Data S3).
We also found that IRE1β failed to form higher-order oligomers
when expressed in HEK293 cells. Oligomerization of IRE1β and
IRE1α was compared using mCherry-tagged constructs and gel
filtration chromatography. As described above, IRE1α-mCherry
eluted from gel filtration as a mix of species with elution peaks
of ∼13.0 ml and 14.0 ml (Fig. 7 E, purple tracing). Based on
elution of molecular weight standards, we propose that these
correspond to tetramer and dimer configurations, respectively;
and, endonuclease activity predominantly coeluted with the
higher-molecular-weight tetramer species (Fig. 6, D and E). The
enzymatically active higher molecular weight form of IRE1α
appeared to be phosphorylation dependent, as the kinase-dead
IRE1α(K599A) mutant eluted from gel filtration in the lower-
molecular-weight fractions (Fig. 7 F, top panel). IRE1β-mCherry
on the other hand, eluted from gel filtration considerably later
than IRE1α at 14 ml and 15 ml, which we propose are dimeric
and monomeric configurations, respectively (Fig. 7 E, light
green tracing), similar to the kinase-dead version of IRE1α.
Consistent with the weaker kinase activity seen in WT IRE1β,
Figure 7. IRE1β has impaired phosphoryla-
tion and does not form higher-order oligom-
ers. (A) XBP1 splicing luciferase reporter activity
measured for HEK293T cells cotransfected with
reporter and control vector or IRE1α(K599A) ex-
pression vector. Bars and error bars represent mean
values ± SEM; significance is indicated by asterisks
(*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P <
0.0001). (B)Gel filtration chromatograms for lysates
of HEK293 cells transfected with IRE1α-mCherry or
IRE1α-mCherry + IRE1α(K599A). IRE1α elution was
monitored bymCherry fluorescence (solid lines) and
endonuclease activity was measured for indicated
fractions (symbols and dashed lines). (C) In vitro
kinase activity measured for purified full-length
IRE1α and IRE1β using ADP-Glo luciferase assay.
Bars represent values from a single experiment.
Results are representative of two independent ex-
periments that have variable baseline (buffer
control) luminescence (RLU, relative lumines-
cence). (D) Schematic of IRE1α and IRE1β kinase
domains illustrates positions of phosphorylation
sites detected by mass spectrometry. Indicated
sites were detected in two independent prepara-
tions of purified protein. (E) Gel filtration chro-
matograms for lysates of HEK293 cells transfected
with IRE1α-mCherry or IRE1β-mCherry expression
vectors, with IRE1 elution monitored by mCherry
fluorescence. Chromatograms are representative
of more than five independent experiments. Elu-
tion positions of proteins with known molecular
weight are indicated above chromatogram. Sche-
matic of putative IRE1 oligomerization states are
shown below chromatograms. (F) Same as in E for
expression and analysis IRE1α-mCherry, IRE1-
α(K599A)-mCherry, IRE1β-mCherry, and IRE1-
β(K547A)-mCherry constructs.
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rendering the kinase domain inactive (by K547A mutation) had
no further effect on the elution profile. Thus, IRE1β has impaired
kinase activity with a different pattern of autophosphorylation
and impaired oligomerization compared with IRE1α. We suggest
that the tendency to form lower-order oligomers explains the
weaker XBP1 splicing activity seen in IRE1β.
A nonconserved amino acid in the kinase domain active site
regulates IRE1 endonuclease activity
To identify structural features that underlie the differential ki-
nase, phosphorylation, and oligomerization features of the two
IRE1 homologues, we analyzed the primary structure of IRE1α
and IRE1β kinase domains. The kinase domains share 80% se-
quence similarity, including conservation of key catalytic and
regulatory residues. One divergent site that stood out was H692
in the kinase domain active site of human IRE1α that is a glycine
(G641) in IRE1β (Fig. 8 A, arrow). In other Ser/Thr kinases, Gln,
Glu, or His typically occupy this position (Singh, 1994) and
contribute side chains that in some instances make contact with
the β-phosphate group of bound nucleotide. In the apo, active
configuration of IRE1α, the side chain of H692 is oriented toward
the flipped-in conformation of the conserved DFG motif (H692
NE2 is 4.8 A˚ from D711 OD2; Feldman et al., 2016). Thus, this
position may be important for either stabilizing an active con-
figuration of IRE1α or enabling nucleotide binding. In either
case, any favorable side chain interactions in IRE1αwould be lost
with a glycine at this position in IRE1β.
To test if the nonconserved His/Gly in the kinase domain
regulates XBP1 splicing, we prepared IRE1α(H692G) and
IRE1β(G641H) mutant constructs, expressed them in HEK293IR-
E1αKO cells, and assayed for XBP1 splicing, phosphorylation, and
oligomerization. The mutant versions of IRE1α and IRE1β were
each expressed at similar levels as their WT counterparts (Fig. 8
B, top panel). Strikingly, the H692G mutation in IRE1α com-
pletely abolished both basal and stress-induced XBP1 splicing
(Fig. 8 B). This was associated with a faster migrating species on
PhosTag SDS-PAGE that was similar to the kinase-dead IRE1-
α(K599A) mutant (Fig. 8 C), suggesting that the H692G mutation
impaired receptor phosphorylation. Impaired phosphorylation
also blocked IRE1α(H692G) oligomerization, as IRE1α(H692G)-
mCherry eluted from gel filtration of cell lysates at lower ap-
parent molecular weight, much like the IRE1α(K599A) mutant
and WT IRE1β (Fig. 8 D).
The reversed G641H mutation in IRE1β, on the other hand,
partially rescued stress-stimulated XBP1 splicing (Fig. 8 B, dark
blue bars on far right; and Fig. S6), and IRE1β phosphorylation,
as evidenced by slower migrating species on PhosTag SDS-PAGE
(Fig. 8 C). The G641H mutation in IRE1β also partially promoted
formation of a higher-molecular-weight species eluting from gel
filtration (Fig. 8 D, bottom panel) and enabled higher levels of
IRE1β endonuclease activity in vitro (Fig. 8 E, left panel). In-
terestingly, an IRE1-specific kinase inhibitor that stabilizes an
active kinase domain conformation and promotes endonuclease
activity (Feldman et al., 2016) was able to stimulate IRE1β en-
donuclease activity to a similar extent as the G641H mutation
(Fig. 8 E, right panel), suggesting that the His at this position may
stabilize an active kinase domain configuration. The IRE1β(G641H)
mutant, however, was still considerably less active than IRE1a
in vitro (Vmax for IRE1β(G641H) was ∼103-fold lower than IRE1α).
When expressed in HEK293 cells, the IRE1βG641H mutant
increased the baseline level of XBP1 splicing comparedwith IRE1β-
transfected cells, but it did not significantly restore the endoge-
nous IRE1α stress response compared with WT IRE1β (Fig. 8 F).
This implies that other molecular features must also contribute.
The reverse IRE1α(H692G) mutant, on the other hand, much like
the kinase-dead IRE1α(K599A) mutant, completely abolished
stress-induced XBP1 splicing by endogenous IRE1α. Together,
these data implicate G641 in IRE1β and H692 in IRE1α as a critical
residue linking the IRE1 kinase domain active site with auto-
phosphorylation, oligomer assembly, and endonuclease activity.
IRE1β and IRE1α variants that are impaired in these functions are,
thus able to modify the UPR by dominant-negative interaction
with IRE1α.
Discussion
Our results delineate a mechanism for down-regulation of the
UPR that is unique to epithelial cells liningmucosal surfaces. The
ER of these cells contains IRE1β, which under conventional
conditions of ER stress interferes with IRE1α signaling by as-
semblingwith IRE1α to inhibit XBP1 splicing (Fig. 9).We propose
that this occurs in a dominant-negative manner, where IRE1β
itself has comparatively weaker XBP1 splicing activity than
IRE1α. A single nonconserved residue in the kinase domain ac-
tive site of IRE1β and IRE1α explains, at least in part, the dif-
ferent endonuclease activities by tuning phosphorylation and
oligomer assembly. As such, IRE1β blocks expression of genes
regulated by XBP1s, including stress-induced expression of
IRE1α itself. Disrupting this stress-induced autofeedback loop
may further enable the down-regulatory effects of IRE1β on
IRE1α to affect the UPR. These results support the idea that IRE1β
has been evolutionarily conserved to dampen the amplified ER
stress responses expected of the host–environment interface and
required for mucosal host defense (Bertolotti et al., 2001).
Steady-state kinetic measurements using full-length deter-
gent solubilized proteins provide direct evidence that IRE1β can
inhibit IRE1α enzymatic activity. In vitro, purified full-length
IRE1β causes an ∼15–25% decrease in IRE1α-dependent cleav-
age of XBP1 substrate (Vmax) under steady-state conditions. This
calculates to a submicromolar inhibitory constant using a non-
competitive inhibition model. Testing the model at higher con-
centrations of IRE1β was not possible in our hands. Still, the
result implicates physiological relevance, as evidenced by our
studies in intact cells. If in vivo some intestinal cells express
IRE1β and IRE1α at 50:1 ratios, as measured by single-cell RNA
sequencing (RNA-seq), this could correspond to >60% inhibi-
tion of IRE1α activity (in vitro) based on the calculated KI of
300 nM. In reality, it is hard to predict how the steady-state
kinetic measurements translate to an in vivo cellular context,
where the relative stoichiometries of IRE1β and IRE1α proteins
in the ER membrane are unknown, or how substrate levels and
IRE1 clustering may affect turnover under conditions of ER
stress. Further studies are needed to better define the kinetic
mechanism, using better-behaved IRE1 fragments and/or model
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Figure 8. A nonconserved amino acid in the kinase domain active site regulates IRE1 endonuclease activity. (A) Top: Sequence alignment for IRE1α and IRE1β
active site and activation loop residues. Conserved sequences are colored yellow (identical) and light yellow (similar). Bottom, left: Ribbon diagram of human IRE1α kinase
and endonuclease domains (PDB 5HGI; Feldman et al., 2016). Residue positions that are not conserved between IRE1α and IRE1β are colored red. Bottom, right: Cartoon
illustrates close-up view of kinase domain active site and position of H692 side chain. (B) IRE1 expression was assayed by immunoblot (anti-Myc; top) and expression of
spliced qPCR transcript was assayed by qPCR for HEK293/IRE1αKO cells transfected with indicated construct (bottom). (C) Samples from B (two independent experiments)
were assayed for phosphorylation status by PhosTag/SDS-PAGE and immunoblot with anti-Myc antibody. Bandmigration position and intensity are plotted under the blot.
Lines indicate the migration position of different phosphorylation species. (D) Gel filtration chromatograms for lysates of HEK293 cells transfected with indicated IRE1-
mCherry constructs. Chromatograms are representative of at least two independent experiments. (E) Left: In vitro endonuclease activitymeasured for affinity-purified IRE1β
and IRE1β(G641H) under steady-state conditions. Reaction velocities were measured as a function of substrate concentration using 10 nM enzyme. Lines show best fit of
Michaelis–Menten equation with KM = 4 ± 8 µM and Vmax = 0.007 ± 0.008 a.u. s−1 for IRE1β and KM = 1.4 ± 0.2 µM and Vmax = 0.027 ± 0.001 a.u. s−1 for IRE1β(G641H).
Right: In vitro endonuclease activitymeasured for 10 nMenzyme and 1 µMXBP1 reporter substrate in the presence or absence of 100µMAT9283 kinase inhibitor. (F)XBP1
splicing luciferase reporter activity for HEK293 cells were transfectedwith indicated IRE1 constructs and treatedwith Tg (300 nM for 4 h, n = 3). In B, E, and F, bars and error
bars represent mean values ± SEM; significance is indicated by asterisks (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001).
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membrane systems, and define the enzyme activity directly in
the cellular context.
IRE1β appears to interact directly with IRE1α to inhibit XBP1
cleavage. Evidence for such a direct interaction includes (1) the
enzymatic activities of IRE1β are not required to suppress IRE1α
signaling, suggesting a structural interaction mechanism; (2)
IRE1β coimmunoprecipitates with endogenous IRE1α under
basal and stress-stimulated conditions; and (3) in biochemical
assays using purified proteins at physiologically relevant stoi-
chiometries, IRE1β noncompetitively inhibits the endonuclease
activity of IRE1α. Given the overall sequence similarity of IRE1β
and IRE1α it is possible that IRE1β could form a heterodimer
with IRE1α that mimics an IRE1α homodimer, or dimers of
heterodimers, although this is likely a weaker interaction than
between IRE1α(K599A) and IRE1α, which suppresses XBP1
splicing to a greater extent. Alternatively, IRE1α homodimers
may assemble with IRE1β homodimers. In either model, in-
corporation of IRE1β into IRE1α oligomers appears to reduce the
functional capacity for XBP1 splicing in response to ER stress. It
appears that all domains of IRE1β are likely involved in as-
sembling with IRE1α, as we still find inhibition of IRE1α by
IRE1β lacking the endonuclease domain or lacking both the
endonuclease and kinase domains together (data not shown).
This suggests that the lumenal domain, which contributes to IRE1α
oligomerization (Karago¨z et al., 2017), may make an important
contribution.
The comparatively weaker XBP1 splicing activity exhibited
by IRE1β enables the protein to act in a dominant-negative
manner to suppress IRE1α XBP1 splicing. We identified one
molecular feature that contributes to the different endonucle-
ase activities for the two proteins, a nonconserved amino acid
in the kinase domain active site that links autophosphorylation
and oligomerization with XBP1 cleavage activity. Exactly how
the G641 residue regulates IRE1β kinase activity and ultimately
endonuclease outputs, however, remains inconclusively ex-
plained. Since the small-molecule kinase inhibitor AT9283 acts
to stimulate the endonuclease activity of IRE1β to a similar
extent as the G641H mutation, presumably by stabilizing the
active conformation of the kinase domain as it does in IRE1α
(Feldman et al., 2016), we propose that G641 acts to disable the
conformational stability of the kinase domain. As the confor-
mation of the kinase domain active site has been linked to re-
ceptor assembly and signal transduction outputs in some
contexts (Mi et al., 2011), it is possible that a destabilized kinase
domain active site conformation in IRE1β impairs oligomeri-
zation and confers weaker endonuclease and XBP1 splicing
activity. Rescue of the G641 residue by substitution with His,
however, does not completely revert IRE1β to full IRE1α-like
activity. It is possible that phosphorylation of Ser/Thr resi-
dues outside of the activation loop affect IRE1β oligomerization.
There are other notable structural differences between the two
proteins, such as in the lumenal, transmembrane, and cytosolic
juxtamembrane domains, that also may affect protein function
and assembly with IRE1α.
Remarkably, IRE1β does not appear to affect RIDD during ER
stress. This could be because RIDD signaling during ER stress
occurs from lower-order IRE1α oligomers, as proposed before
(Tam et al., 2014), which are unaffected by IRE1β expression. In
resting cells, however, many gene transcripts have lower ex-
pression when IRE1β is present. We also observe enhanced XBP1
transcript levels in cells at rest when expressing IRE1β. Thus,
IRE1β might act as a constitutively active endonuclease cleaving
RIDD substrates as well as contributing a baseline level of spliced
XBP1 transcript. Further cell-based and structural studies are
needed to define the IRE1β–IRE1α interaction and how distinct
IRE1β/IRE1α assemblies confer preference for XBP1 cleavage
versus RIDD activity. Likewise, other ER proteins (Amin-Wetzel
et al., 2017; Bertolotti et al., 2000; Sepulveda et al., 2018;
Sundaram et al., 2017) andmediators of apoptosis (Lisbona et al.,
2009; Shemorry et al., 2019) also regulate IRE1α activity. How
IRE1β affects these interactions and regulatory mechanisms also
remain to be determined.
Figure 9. IRE1β functions as a dominant-negative suppressor of IRE1α signaling. Schematic illustrates model for IRE1β interacting with IRE1α oligomers in
a manner to suppress stress-induced XBP1 splicing.
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As a consequence of inhibiting IRE1α endonuclease activity,
IRE1β attenuates the production of the well-described tran-
scription factor XBP1 in response to ER stress. Since XBP1 binds
promoters of genes throughout the genome, the effect of IRE1β
on basal and stress-induced XBP1 splicing will likely have an
impact on many gene expression programs, including those
responsive to other arms of the UPR (Acosta-Alvear et al., 2007).
This function of IRE1β to suppress IRE1α signaling may be fun-
damentally important for the physiology of the intestine and
other mucosal surfaces. Surface epithelial cells face a diverse
array of environmental factors that may cause cell damage and
activate or modify cellular stress responses affecting the UPR. As
unresolved ER stress and prolonged UPR signaling induces cell
death, such responses left unchecked are likely harmful to
mucosal barriers. Our results explain the mechanism of action
and concur with the idea that IRE1β has been conserved to buffer
IRE1α and XBP1 signal transduction against stimuli encountered
by epithelial cells at the host–environment interface.
Materials and methods
Caco2 and T84 cell culture
Caco2BBE cells were maintained in DMEM supplemented with
15% FBS, and T84 cells were maintained in 1:1 DMEM/F12 media
supplemented with 6% newborn calf serum. Cells were plated on
1-cm2 Transwell inserts (0.4-µm pore size polycarbonate mem-
branes for Caco2 cells and 3-µm pore size polyester membranes
for T84 cells) and allowed to polarize for 7 d. Transepithelial
electrical resistance was measured using an epithelial volt/Ohm
meter (EVOM; World Precision Instruments) to assess mono-
layer formation. Monolayers were treated with Tg (3 µM final)
or DMSO as controls in apical and basolateral compartments for
2 h at 37°C. Cells werewashed twice with ice-cold PBS and stored
at −80°C.
Colonoid culture
All housing and procedures involving live vertebrate animals
were reviewed and approved by Boston Children’s Hospital
Institutional Animal Care and Use Committee. IRE1β+/+ and
IRE1β−/− mice were euthanized. The colon was excised, fecal
pellets were removed, and the tissue was flushed with 5 ml of
ice-cold PBS. The colon was opened longitudinally and cut into
several small (2- to 3-mm) pieces. Tissue pieces were washed
two or three times in PBS and placed in PBS with 10 mM EDTA
for 45 min with end-over-end rotation at 4°C. Crypts were
dissociated by vigorous shaking for 5–7 min, and the superna-
tant was collected and diluted twofold with base media (Ad-
vanced DMEM/F12 supplemented with 20% FBS, 10 mM Hepes,
1× Glutamax, and 1× penicillin/streptomycin). Tissue pieces
were incubated a second time with PBS/EDTA and dissociated
cells were collected in the same manner. Collected cells were
passed through a 100-µM strainer followed by a 40-µM
strainer. Cells retained on the 40-µM strainer were washed
with base media, collected with 10 ml base media, and spun
down at 300 ×g for 3 min. Crypts were resuspended in Matrigel
(on ice), and 30 µl drops were plated in 24-well plates. Plates
were inverted and incubated at 37°C to polymerize Matrigel.
Complete media (base media + 50% WRN-conditioned media
prepared from L cells expressing Wnt/R-spondin/Noggin as de-
scribed; Miyoshi and Stappenbeck, 2013) was added to each well
and cultures were incubated at 37°C 5% CO2. Media was changed
every other day. Cultures were passaged every 4–7 d as needed.
Matrigel was dissolved using Cell Recovery Solution (Corning),
cells were enzymatically dissociated with trypsin, and the cell
pellet was resuspended in 1.5- to 2-fold more Matrigel than used
in the previous plating. For experiments, colonoids were plated
in triplicate. At 5 d after plating, colonoids were treated with
SubAA272B or SubAB (100 ng/ml) for 24 h. Matrigel drops were
collected and pooled, and colonoids were recovered using Cell
Recovery Solution, washed once with PBS, and stored at −80°C.
HEK293doxIRE1β cell model
HEK293doxIRE1β cells were established by subsequent transduction
of low-passage HEK293 cells (obtained from the European Col-
lection of Authenticated Cell Cultures) with lentiviral particles
encoding the pLenti3.3 Dox-controlled regulator and pLenti6.3/
V5/ERN2-FLAG (Invitrogen). ERN2-FLAG coding sequence was
introduced by Gateway cloning. All sequences were confirmed by
sequencing. Transduction was performed with concentrated and
tittered virus at multiplicity of infection (MOI) of 1 for pLenti3.3
and MOI of 2 for pLenti6.3, respectively. Cells were treated with
Dox at 0, 10, or 100 ng/ml for 24 h to induce IRE1β expression
followed by treatment with 200 nM Tg to induce ER stress for 1.5,
3, or 6 h as indicated. All time points included a DMSO control
treatment. IRE1α knockdown experiments were performed using
ERN1 TriFECTa RNAi Kit (hs.Ri.ERN1.13; Integrated DNA Tech-
nologies), which includes a nontargeting negative control. siRNAs
were transfected using Lipofectamine RNAi Max according to the
manufacturer’s protocol for 24 h, followed by treatment with 200
nM Tg for 3 h.
Overexpression of IRE1 constructs in HEK293 cells
General molecular biology reagents, including restriction en-
zymes, Phusion HF Mastermix, T4 PNK, CIP, Quick Ligation
Kit, and DH5α competent cells, were from New England Biol-
abs. GeneJet DNA purification kits were from ThermoFisher.
pcDNA4-MycHisB plasmid (ThermoFisher) was digested with
HindIII and EcoRI. Oligonucleotides with HindIII restriction
sites, a Kozak sequence, a start codon, a murine Igκ leader
sequence, a FLAG tag, and an EcoRI restriction site were an-
nealed, phosphorylated with T4 PNK, and ligated into the
HindIII/EcoRI-digested pcDNA4-MycHisB vector. The new
vector called pSecFLAG-MycHis allows for in-frame cloningwith
C-terminal Myc epitope and His tag. Additional pSecFLAG vec-
tors were created with mCherry coding sequence inserted be-
tween NotI and XbaI restriction sites of pSecFLAG (for in-frame
cloning with C-terminal mCherry tag, pSecFLAG-mCherry) or a
streptavidin-binding peptide (SBP) tag immediately upstream of
Myc epitope (pSecFLAG-SBP-MycHis). IRE1α (S24-L977), IRE1β
(L35-R925), and IRE1β deletion construct (L35-S782, L35-R452)
coding sequences were PCR amplified from IRE1α and IRE1β
templates (provided by K. Kohno, Nara Institute of Science and
Technology, Ikoma, Japan) using primers with EcoRI and NotI
restriction sites. PCR-amplified products were digested and
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ligated into EcoRI/NotI-digested pSecFLAG-MycHis, pSecFLAG-
mCherry, or pSecFLAG-SBP-MycHis vectors. IRE1α(K599A),
IRE1α(H692G), IRE1β(K547A), and IRE1β(G641H) mutations were
introduced using QuickChange Lightning Site-Directed Mutagen-
esis Kit (Agilent). All constructs were confirmed by restriction
digest and sequencing (Harvard Biopolymer Facility).
HEK293T, HEK293, and HEK293IRE1αKO cells were main-
tained in DMEM supplemented with 10% FBS. Cells were seeded
in 24-well plates at a density of 1–2 × 105 cells/well in 0.5 ml
media. At 24 h after plating, cells were transfected with IRE1
expression plasmids or pcDNA4 as control (500 ng per well)
using polyethyleneimine (PEI; linear 25 kD; Polysciences) at a
DNA/PEI mass ratio of 1:3. At 18–24 h after transfection, cells
were treated with Tg or SubAB along with appropriate controls
as described in the figure legends. After treatment, cells were
washed twice with ice-cold PBS and used for RNA extraction or
preparation of whole-cell lysates.
Expression analysis by qPCR
Total RNA was extracted from cell lines and colonoids using the
RNeasy Mini Kit (Qiagen). Cell pellets were lysed in Buffer RLT,
homogenized with QiaShredder (Qiagen), and processed ac-
cording to the manufacturer’s protocol (including on-column
DNase digest). Total RNA concentrations were measured by
absorbance at 260 nm, and quality was assessed by A260/A280
ratios. Total RNA (typically 500 ng) was used as a template for
cDNA synthesis using iScript cDNA synthesis kit (BioRad).
Target transcripts were amplified using primers listed in Table
S1 and Sso Advanced Universal SYBR Green Supermix according
to the manufacturer’s protocol (BioRad). All qPCR reactions
were assayed in triplicate for each sample, and the average Cq
value was used to calculate the mean expression ratio of the test
sample compared with the control sample (i.e., stress treated
compared with control treated) using the 2-ΔΔCt method. Cq
values for targets were analyzed relative to Cq values for hprt,
ppia, and gapdh housekeeping genes.
Western blots
Whole-cell lysates were prepared in RIPA buffer supplemented
with Complete Protease Inhibitor (100 µl per cm2 surface area of
cells). Cells were lysed on ice for 15 min. Lysates were cleared by
centrifugation at 16,800 ×g for 10 min. Total protein was mea-
sured using BCA assay. Typically, 10–25 µg of total protein was
separated on reducing SDS-PAGE (4–15% or 4–20% gradient gels;
BioRad). Proteins were transferred to nitrocellulose membranes
and blocked with 5% dry milk in TBS with 0.1% Tween-20 (TBS/
T) buffer. Membranes were incubated with primary antibody
(diluted in 5% milk, TBS/T) for 1 h at room temperature or
16–24 h at 4°C, washed 3× with TBS/T, and incubated HRP-
conjugated secondary antibody (diluted in 5% milk, TBS/T) for
1 h at room temperature. Membranes were washed three times
with TBS/T, developed with SuperSignal West Femto Maximum
Sensitivity Substrate (ThermoFisher), and imaged using Azure
c300 Chemiluminescent Western Blot Imaging System (Azure
Biosystems). Membranes were stripped with Restore Stripping
Buffer (ThermoFisher) and reprobed as needed. Band intensities
were quantified using ImageJ. Antibodies used include anti-
IRE1α (14C10, 1:1,000; Cell Signaling Technologies), anti-IRE1β
(PA5-13921, 1:2,000; ThermoFisher), anti-Myc tag (9B11, 1:2,000;
Cell Signaling Technologies), anti-FLAG (M2 F1804, 1:1,000;
Sigma), anti-XBP1 (M186, sc-7160 1:200; Santa Cruz Biotech-
nology), and anti-βactin (AC-15, A5441 1:5,000; Sigma). Sec-
ondary antibodies used include HRP-conjugated anti-rabbit IgG
(A6154, 1:5,000–1:10,000; Sigma) and HRP-conjugated anti-
mouse IgG (A4416, 1:5,000–1:10,000; Sigma,).
Luciferase reporter assays
pCAX-HA-2xXBP1-Luc-F (XBP1 splicing reporter) was provided
by T. Iwawaki (Kanazawa Medical University, Uchinada, Japan;
Iwawaki and Akai, 2006). pGL3-5XUPRE-Luc was provided by
Ron Prywes (Columbia University, New York, NY; Addgene
plasmid 11976; Wang et al., 2000). hIRE1α-1153/+114-Luc and
hIRE1α−300/+114-Luc reporter vectors were prepared by PCR
amplifying the specified IRE1α promoter region from a synthetic
gBlock Gene Fragment (IDT) with NheI and NcoI restriction
sites. Restriction-digested, gel-purified PCR products were li-
gated into NheI–NcoI–digested pGL3-basic vector (Promega)
immediately upstream of the luciferase start codon. HEK293T or
HEK293 cells (0.5 × 105 cells/well) were seeded in 96-well plates
and reverse transfected with protein expression vectors and
inducible luciferase reporter vectors at a 1:1 ratio with 100 ng total
DNA per well. Mock transfections included pcDNA4-MycHisB
vector and inducible luciferase vector. An untransfected control
was also included that did not have the luciferase vector for
background correction. At 18–24 h after transfection, cells were
treated with 3 µM Tg or 100 ng/ml subtilase toxin (or inactive
mutant toxin SubAA272B) for 4–8 h, lysed, and assayed for lucif-
erase activity using Bright-Glo luciferase assay system (Promega).
Luminescence was measured using Tecan Spark 10M plate reader.
The background signal from untransfected cells was subtracted
from all data.
Coimmunoprecipitation studies
For the inducible cell line, 8 × 106 HEK293doxIRE1β cells were
seeded in 100-mm dishes. The next day, IRE1β-FLAG expres-
sion was induced with 100 ng/ml DOX for 24 h. For transient
overexpression, 8.2 × 106 HEK293T cells were seeded in 100-
mm dishes. The next day, IRE1β-FLAG plasmid was trans-
fected using PEI at a 1:5 DNA/PEI ratio (5 µg DNA). Cells were
collected after 24 h. Cells were lysed in lysis buffer (0.1% NP-
40, 10% glycerol, 250 mM NaCl, 20 mM Hepes, pH 7.9, and
1 mM EDTA) with protease and phosphatase inhibitors.
Samples were incubated with 10 µl prewashed Dynabeads T1
(Invitrogen) that were either prebound with BioM2 anti-FLAG
(Sigma; 1 µl antibody/10 µl beads) or no antibody for 1 h at 4°C.
After washing with lysis buffer, bound proteins were eluted
directly in sample buffer and samples were separated on a
4–12% Criterion Bis-Tris gel (BioRad). Proteins were trans-
ferred to polyvinylidene difluoride membrane (Immobilon-
FL; Millipore), and incubate with anti-IRE1a (1/1,000; 14C10;
Cell Signaling Technology), M2 anti-FLAG (1/1,000; Sigma),
and anti-tubulin (1/2,000; Sigma). Proteins were revealed
with anti-mouse and anti-rabbit HRP-conjugated antibodies
(1/15,000; Jackson Immuno AffiniPure).
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IRE1 oligomerization assays
To assay oligomerization of endogenous IRE1α in HEK293doxIRE1β
cell line, cells were resuspended in 25mMTris, pH 8.0, 150mM
NaCl, 20 mM dodecylmaltoside, 5 mM β-mercaptoethanol, 1×
Complete Protease Inhibitor, and 1× PhosSTOP (0.5 ml lysis
buffer per 10 cm2 surface area of cells), transferred to a 1.5-ml
tube, and lysed at 4°C with end-over-end rotation for 1 h. Lysate
was cleared by centrifugation at 16,000 ×g for 10 min. 250 µl of
cleared lysate was fractionated on a Superose6 Increase 10/30
gel filtration column (GE Healthcare) equilibrated in running
buffer (25 mM Tris, pH 8.0, 150 mM NaCl, 0.5 mM dode-
cylmaltoside, and 5 mM β-mercaptoethanol) at 0.5 ml/min.
Fractions (0.2 ml) were collected in a 96-well plate from 6 ml
to 24 ml elution. Fractions were assayed by SDS-PAGE and
Western blot with anti-IRE1α antibody to detect endogenous
IRE1α.
HEK293 cells were plated at 8 × 105 cells/well in 6-well plates.
The next day, pSecFLAG-IRE1α-mCherry or pSecFLAG-IRE1β-
mCherry constructs were expressed by transient transfection
using PEI at a 1:3 DNA/PEI ratio (2.5 µg total DNA per well). In
cases where IRE1-mCherry constructs were cotransfected with
unlabeled IRE1 constructs, they were included at equal amounts
or cotransfected with pcDNA4 as a control. At 24 h after trans-
fection, cells were collected, lysed, and fractionated as described
above. Fractions were assayed by measuring mCherry fluores-
cence using Tecan Spark 10M plate reader (excitation at 570 nm
and emission at 620 nm) to detect elution of IRE1-mCherry.
Background fluorescence was subtracted, if needed, by taking
the average of the first 10 fractions and last 10 fractions. For
reinjection experiments (Fig. 6 C), defined high-molecular-
weight fractions from the original fractionated lysate were
reinjected on Superose6 column. IRE1-mCherry elution was
monitored by fluorescence. Endonuclease activity was moni-
tored for each fraction in 96-well format as described below
using 1 µM substrate and measuring fluorescence at the 60-min
time point.
Expression and purification of full-length IRE1 constructs
Full-length IRE1 constructs for purification were expressed in
the Expi293 Expression System (ThermoFisher). Expi293F cells
were maintained and expanded in Expi293 Expression Me-
dium. Cells were transfected with pSecFLAG-IRE1-SBP-MycHis
expression plasmids according to the manufacturer’s protocol
using 1 µg DNA per ml of culture volume. At 48 h after trans-
fection, cells were collected, washed once with ice-cold PBS,
and resuspended at ∼20 × 106 cells/ml in lysis buffer (25 mM
Tris, pH 8.0, 150 mM NaCl, 20 mM dodecylmaltoside, 5 mM
β-mercaptoethanol, 1× Complete Protease Inhibitor [Sigma],
and 1× PhosSTOP phosphatase inhibitor [Sigma]). Cells were
lysed for 1 h at 4°C with end-over-end rotation. Lysate was
cleared by centrifugation at 30,000 ×g for 15 min. Cleared ly-
sate was applied by gravity flow to a 0.5–1.0 ml StrepTactin
Sepharose column equilibrated in wash buffer (25 mM Tris, pH
8.0, 300 mM NaCl, 1 mM dodecylmaltoside, and 5 mM
β-mercaptoethanol). Column was washed four times with 5 ml
of wash buffer. Bound protein was eluted with 8× 0.5-column
volumes of elution buffer (25 mM Tris, pH 8.0, 150 mM NaCl,
1 mM dodecylmaltoside, 5 mM β-mercaptoethanol, and 2.5 mM
desthiobiotin). Samples of elution fractions were assayed by
SDS-PAGE and detected by colloidal Coomassie staining or by
Western blot with anti-IRE1α, anti-IRE1β, or anti-Myc anti-
bodies. Coomassie-stained bands were excised, digested with
trypsin, and assayed by liquid chromatography with tandem
mass spectrometry for protein identification and phospho-
peptide mapping (Taplin Mass Spectrometry Facility, Harvard
Medical School). In some cases, further purification of samples
was performed by gel filtration chromatography on Superose6
column equilibrated in 25 mM Tris, pH 8.0, 150 mM NaCl,
0.5 mM dodecylmaltoside, and 5 mM β-mercaptoethanol.
In vitro endonuclease assays
An XBP1 RNA stem-loop model substrate was synthesized with
a 59-FAM and 39-BlackHoleQuencher (IDT): 59-FAM-CAU-
GUCCGCAGCGCAUG-BHG-39 (Wiseman et al., 2010). Endonu-
clease assays were performed in 96-well plates (80–100 µl
reaction volume) or 384-well plates (20 µl reaction volume).
Purified enzyme or gel filtration fractions were diluted twofold
with 2× endonuclease reaction buffer containing substrate (at
indicated concentrations) to give final conditions of 50 mM
Tris, pH 7.5, 150 mM NaCl, 10 mM MgCl2, 1 mM ATP, 10 mM
DTT, 0.5 mM dodecylmaltoside, and 1× substrate. Formation of
cleaved reaction product was monitored by fluorescence using
Perkin Elmer VictorX or Tecan Spark 10M plate reader with
excitation at 485 nm and emission at 535 nm. In all cases,
background was corrected using a buffer-only (no enzyme)
control reaction. For steady-state kinetic measurements, reac-
tion velocities were determined from the initial change in
fluorescence as a function of time. Velocity versus [substrate]
data were analyzed using Michaelis–Menten or enzyme in-
hibitor models in Prism.
In vitro kinase assays
Purified IRE1 enzyme was incubated with 2× kinase buffer in a
final volume of 25 µl (125 nM enzyme, 70mMTris, pH 7.6, 75 mM
NaCl, 10 mM MgCl2, 5 mM DTT, 1 mM ATP, and 0.5 mM dode-
cylmaltoside) for 30 min at room temperature. ADP produced
from autophosphorylation was detected using the ADP-Glo Kinase
Assay (Promega). Luminescence intensity was measured on a
Perkin Elmer VictorX plate reader. A no-enzyme control (buffer
only) was used to control for the depletion of ATP in kinase re-
action before detection of ADP.
Statistical analysis
In most cases, data consisted of three or more independent ex-
periments. Unless otherwise indicated in figure legend, figures
include all independent measures (n = 3) shown as symbols and
bars represent mean values ± SEM. For expression data, fold
changes (e.g., stress compared with control) were transformed
to log2 scale, and mean values were compared using one-way or
two-way ANOVA, as appropriate, with multiple comparisons
corrected using statistical hypothesis testing (Tukey). Mean
values between two groups were compared using unpaired
Student’s t test (two sided). In all cases, data distribution was
assumed to be normal, but this was not formally tested. In
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figures, significance is indicated by asterisks (*, P < 0.05; **, P <
0.01; ***, P < 0.001; ****, P < 0.0001). All analyses were per-
formed in Prism (GraphPad Software).
Online supplemental material
Fig. S1 shows expression of IRE1β in intestinal epithelial cells and
cell models (supports Fig. 1). Fig. S2 shows that IRE1β suppresses
XBP1 transcriptional activity (supports Fig. 2). Fig. S3 shows that
IRE1β restricts stress-induced IRE1α expression (supports Fig. 3)
and the effect of transient IRE1β expression on IRE1α protein
levels in HEK293T cells. Fig. S4 shows that IRE1β interacts with
IRE1β (supports Fig. 5) and shows IRE1β-IRE1α coimmunopre-
cipitation experiments in HEK293 cells. Fig. S5 shows expres-
sion and XBP1 splicing activity of IRE1 constructs (supports
Fig. 6). Fig. S6 shows that IRE1β-G641H mutant rescues XBP1
splicing (supports Fig. 8 B). Table S1 shows primer sequences
used for qPCR. Data S1 shows differential expression of UPR,
XBP1, and RIDD genes in HEK293doxIRE1β cells. Data S2 shows
putative XBP1 binding sites in human IRE1α promoter region.
Data S3 shows mass spectrometry of phosphorylation sites in
IRE1α and IRE1β proteins purified from Expi293 cells.
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Supplemental Material
Figure S1. Expression of IRE1β in intestinal epithelial cells and cell models. Supports Fig. 1. (A) Violin plots for expression of IRE1β and IRE1α transcripts in
transcriptionally defined cell populations from mouse small intestine. Lines indicated median values. Data are from GSE92332 (Haber et al., 2017). The ratio of
IRE1β/IRE1α expression for individual cells is plotted for goblet and Paneth cell populations. (B) IRE1β protein expression (top) and XBP1 and IRE1α mRNA
expression for HEK293mock cell line treated Dox and Tg as indicated (bottom; n = 3). The anti-FLAG and anti-βactin blots are duplicated from Fig. 1 C to include
HEK293doxIRE1β cells and HEK293mock cells from the same experiment. Bars and error bars represent mean values ± SEM; significance is indicated by asterisks
(*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001).
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Figure S2. IRE1β suppresses XBP1 transcriptional activity. Supports Fig. 2. (A) HEK293T cells were cotransfected with UPRE-luciferase reporter and
indicated plasmids, treated with Tg for 8 h, and assayed for luciferase activity. Activity is plotted relative to mock-transfected cells without Tg (n = 3). (B and C)
Spliced XBP1 mRNA (B; n = 3) and XBP1 protein levels (C; n = 5) in HEK293T cells with control plasmid or IRE1β expression plasmid and treated with Tg for 4 h.
Bars and error bars represent mean values ± SEM; significance is indicated by asterisks (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001).
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Figure S3. IRE1β restricts stress-induced IRE1α expression. Supports Fig. 3. Top: IRE1α protein detected by immunoblot for HEK293T cells transiently
transfected with control plasmid or IRE1β expression plasmid and treated with Tg for indicated time points. Bottom: Actin-normalized band intensities from
immunoblots plotted as log2 fold change compared with untreated (no Tg) mock-transfected cells (n = 5). Bars and error bars represent mean values ± SEM.
Figure S4. IRE1β interacts with IRE1α. Supports Fig. 5. IRE1α and IRE1β protein detected by immunoblot of anti-FLAG immunoprecipitated (IP) samples or
total lysates from HEK293 or HEK293/IRE1αKO cells transfected with IRE1β-FLAG expression construct. Endogenous IRE1α was detected with anti-IRE1α
antibody and IRE1β was detected with anti-FLAG antibody. Blots are representative of three independent experiments.
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Figure S5. Expression and XBP1 splicing activity of IRE1 constructs. Supports Fig. 6. (A) IRE1α protein was assayed by immunoblot (top), spliced and
unspliced XBP1 transcript was assayed by PCR and gel electrophoresis (middle), and spliced XBP1 transcript was assayed by qPCR (bottom) for HEK293 or
HEK293/IRE1αKO cells treated with DMSO, Tg, or tunicamycin (Tm; n = 3). (B) IRE1 protein expression was assayed by immunoblot (top), and spliced XBP1
transcript was assayed by qPCR (bottom) for HEK293/IRE1αKO cells transfected with indicated expression vector and treated with DMSO, Tg, or tunicamycin
(n = 3). (C) XBP1 splicing luciferase reporter activity for IRE1α constructs transfected in HEK293/IRE1αKO cells. Activity is plotted relative to the untreated (no
Tg), mock-transfected cells. Bars represent mean of two independent experiments. Bars and error bars represent mean values ± SEM; significance is indicated
by asterisks (*, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001).
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Provided online are one table and three datasets. Table S1 lists the primer sequences used for expression analysis by qPCR. Data S1
shows differential expression of UPR, XBP1, and RIDD genes in HEK293doxIRE1β cells. Data S2 shows putative XBP1 binding sites in
the human IRE1α promoter region. Data S3 shows mass spectrometry of phosphorylation sites in IRE1α and IRE1β proteins purified
from Expi293 cells.
Figure S6. IRE1β-G641H mutant rescues XBP1 splicing. Supports Fig. 8 B. Spliced XBP1 transcript assayed by qPCR for HEK293/IRE1αKO cells transfected
with indicated IRE1 constructs and treated with Tg. Bars represent a single independent experiment. These data were not included in Fig. 8 B because the
response measured for IRE1α- and IRE1β(G641H)-transfected cells in this experiment was ∼10-fold greater in magnitude than any of the other experiments.
Although not included in the analysis in Fig. 8 B, the results from this experiment further support the conclusion that IRE1α(H692G) abolishes XBP1 splicing and
IRE1β(G641H) rescues stress-induced XBP1 splicing activity.
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